Compounds > valsartan
Page last updated: 2024-08-24

valsartan and Arteriosclerosis

valsartan has been researched along with Arteriosclerosis in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's5 (50.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mookherjee, S; Safar, ME; Smulyan, H1
Williams, B1
Guan, S; Wang, B1
Chen, R; Cui, TX; Gao, XY; Horiuchi, M; Iwai, M; Jinno, T; Li, Z; Liu, HW; Okumura, M; Suzuki, J; Tsuda, M; Wu, L1
DI, J; Huang, ST; Lei, XY; Li, JM; Lu, YS1
Ito, S; Kageyama, N; Nakaya, Y; Nomura, M; Watanabe, T1
Arai, Y; Hirose, N; Kawamura, M; Li, J1
Lippert, TH; Mueck, AO; Seeger, H1
Aragoncillo, P; Cachofeiro, V; de las Heras, N; DeGasparo, M; Lahera, V; Maeso, R; Mann, J; Navarro-Cid, J; Ruilope, LM; Vazquez-Pérez, S1
Cachofeiro, V; Cediel, E; de Las Heras, N; Lahera, V; Oubiña, MP; Ruilope, LM; Sanz-Rosa, D; Vázquez-Pérez, S1

Reviews

2 review(s) available for valsartan and Arteriosclerosis

ArticleYear
The two faces of hypertension: role of aortic stiffness.
    Journal of the American Society of Hypertension : JASH, 2016, Volume: 10, Issue:2

    Topics: Aging; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Arteriosclerosis; Biphenyl Compounds; Blood Pressure; Diastole; Drug Combinations; Humans; Hypertension; Microcirculation; Prevalence; Pulse Wave Analysis; Pyridines; Risk Factors; Systole; Tetrazoles; Thiazepines; Valsartan; Vascular Resistance; Vascular Stiffness

2016
Vascular ageing and interventions: lessons and learnings.
    Therapeutic advances in cardiovascular disease, 2016, Volume: 10, Issue:3

    Topics: Aging; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Biphenyl Compounds; Blood Pressure; Drug Combinations; Humans; Hypertension; Tetrazoles; Valsartan; Vascular Stiffness

2016

Other Studies

8 other study(ies) available for valsartan and Arteriosclerosis

ArticleYear
Effects of fosinopril and valsartan on expressions of ICAM-1 and NO in human umbilical vein endothelial cells.
    Chinese medical journal, 2003, Volume: 116, Issue:6

    Topics: Arteriosclerosis; Cells, Cultured; Endothelium, Vascular; Fosinopril; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Nitric Oxide; Nitric Oxide Synthase; Tetrazoles; Umbilical Veins; Valine; Valsartan

2003
Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Arteriosclerosis; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Mice; Mice, Knockout; Oxidative Stress; Tetrazoles; Valine; Valsartan

2004
[The effect of captopril and valsartan on preventing the formation of atherosclerotic plaque].
    Zhonghua nei ke za zhi, 2005, Volume: 44, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Arteriosclerosis; Captopril; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Male; Rabbits; Tetrazoles; Ultrasonography; Valine; Valsartan

2005
Relationship between adhesion molecules with hs-CRP and changes therein after ARB (Valsartan) administration in patients with obstructive sleep apnea syndrome.
    The journal of medical investigation : JMI, 2006, Volume: 53, Issue:1-2

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; C-Reactive Protein; Case-Control Studies; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Myocardial Ischemia; Sleep Apnea, Obstructive; Tetrazoles; Valine; Valsartan

2006
Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits.
    Atherosclerosis, 1999, Volume: 143, Issue:2

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Arteriosclerosis; Benzazepines; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Rabbits; Reference Values; Tetrazoles; Valine; Valsartan

1999
Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery.
    International journal of clinical pharmacology and therapeutics, 1999, Volume: 37, Issue:7

    Topics: Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Cell Count; Cell Division; Cells, Cultured; Coronary Vessels; Female; Humans; Muscle, Smooth, Vascular; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents

1999
AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:4 Pt 2

    Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Arteriosclerosis; Endothelium, Vascular; Male; Rabbits; Receptors, Angiotensin; Tetrazoles; Tunica Intima; Valine; Valsartan

1999
Valsartan improves fibrinolytic balance in atherosclerotic rabbits.
    Journal of hypertension, 2002, Volume: 20, Issue:2

    Topics: Acetylcholine; Animals; Antihypertensive Agents; Arteriosclerosis; Biomarkers; Blood Pressure; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Dose-Response Relationship, Drug; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hypercholesterolemia; Male; Myocardial Contraction; Rabbits; Tetrazoles; Time; Treatment Outcome; Valine; Valsartan

2002